1. Introduction {#sec0005}
===============

Gastric cancer is the fourth most common malignancy worldwide \[[@bib0005]\]. Endoscopic examination and biopsy from the surface of the tumor are essential for the diagnosis because most gastric cancers are derived from the mucosal epithelial cells. However, the preoperative diagnosis of gastric cancer presenting as submucosal tumor (SMT) is difficult, as it is typically covered with non-malignant epithelial mucosa \[[@bib0010]\]. Moreover, the clinical and pathological characteristics of gastric carcinoma with features of a submucosal tumor (GCSMT) remain unclear because of the limited number of reported cases \[[@bib0010],[@bib0015]\]. We report a rare case of GCSMT diagnosed preoperatively by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) and boring biopsy (deeper biopsy). Boring biopsy is a method of digging into the gastric mucosa using a forceps to obtain the tissue specimens of the gastric SMT. We also conduct a literature review on GCSMT. This case has been reported in line with the SCARE criteria \[[@bib0020]\].

2. Case presentation {#sec0010}
====================

An 81-year-old man was admitted to our hospital because of gastric SMT that was noted during an annual gastrointestinal examination. He had a history of type 2 diabetes mellitus and myocardial infraction treated with anticoagulant therapy, percutaneous intervention, and coronary artery bypass graft. His blood examination results were within normal range, but the tumor marker levels were high: carcinoembryonic antigen, 16.8 ng/mL (normal, \<5.0 ng/mL) and α-fetoprotein (AFP), 83.5 ng/mL (normal, \<10.0 ng/mL). Endoscopic examination of the gastrointestinal tract revealed SMT (approximately 30 mm in diameter) located at the lower gastric body and with erosion on the top of the tumor ([Fig. 1](#fig0005){ref-type="fig"}A). Endoscopic ultrasonography (EUS) revealed that the tumor presented as a well-defined hypoechoic mass (22 × 12 mm) arising from the submucosal layer of the stomach ([Fig. 1](#fig0005){ref-type="fig"}B). Endoscopic biopsy of the erosion site revealed no malignancy. EUS-FNA and boring biopsy were performed. Histopathological evaluation revealed that the tumor had dense proliferation of larger atypical cells. Immunohistochemical analysis revealed that these tumor cells were positive for Caudal-type homeobox-2 (CDX-2) and negative for synaptophysin and chromogranin A. These findings suggested that the SMT originated from a gastrointestinal adenocarcinoma. Contrast-enhanced computed tomography revealed a 30-mm tumor located in the gastric vestibule and an enlarged lymph node No. 6 (22 mm). Hence, the preoperative diagnosis was gastric carcinoma with lymph node metastasis.Fig. 1Preoperative endoscopic examination and endoscopic ultrasonography.(A) Endoscopic image of the submucosal tumor. The surface of the lesion is covered by non-malignant mucosa with erosion (arrow).(B) Endoscopic ultrasound examination showed a well-defined hypoechoic mass (22 × 12 mm), which originates from the submucosal layer of the stomach.Fig. 1

We performed distal gastrectomy with D2 lymph node dissection and Roux-en-Y reconstruction after obtaining informed consent from the patient. The resected specimen showed a tumor (35 × 18 mm) located at the lower body of the stomach. Postoperative histopathological examination of the specimen revealed a poorly differentiated adenocarcinoma with high lymphocyte proliferation in the peripheral tumor. Although the tumor invaded the muscularis propria, the tumor surface was covered with non-malignant epithelial mucosa ([Fig. 2](#fig0010){ref-type="fig"}). Moreover, immunohistochemical analysis demonstrated that napsin and AFP were negatively expressed and CDX-2 was diffusely expressed. Epstein-Barr virus (EBV)-encoded RNA-1 (EBER-1) in situ hybridization confirmed the absence of EBV in gastric tumor cells. Metastasis of the adenocarcinoma was found in 1 (No. 6) of 41 excised lymph nodes. The postoperative pathological stage was IIA (T2N1cM0), according to the Japanese classification of gastric cancer \[[@bib0025]\].Fig. 2Histological features. Components of a poorly differentiated adenocarcinoma invaded the muscularis propria. The tumor was almost entirely covered with non-malignant epithelial mucosa.Fig. 2

The patient was discharged on the postoperative day 19 without any complications. Although he refused adjuvant chemotherapy, no recurrence or metastasis occurred during the follow-up period of 18 months.

3. Discussion {#sec0015}
=============

Gastric SMTs consist of a variety of neoplastic and non-neoplastic conditions arising from deeper layers of the gastric wall, such as gastrointestinal stromal tumors (GIST), schwannomas and malignant lymphomas \[[@bib0030]\]. GCSMT is a rare disease with an incidence of 0.1 to 0.63% of all gastric cancer \[[@bib0010]\]. The clinical and pathological findings of these lesions remain unclear because of a few numbers of reported cases. Herein, we reviewed 19 cases (17 case reports) published in English, including our case, in order to elucidate the clinical characteristics of GCSMT ([Table 1](#tbl0005){ref-type="table"}) \[[@bib0010],[@bib0015],[@bib0035], [@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080], [@bib0085], [@bib0090], [@bib0095], [@bib0100], [@bib0105]\].Table 1Previous case reports of gastric cancer resembling submucosal tumor following curative surgery.Table 1AuthorAgeSexTumor locationMaximal tumor sizeEndoscopic resectionSurgeryTNM classification[a](#tblfn0005){ref-type="table-fn"}Type of tissueOhara48MaleL20 mmSub TG3, 0, 0, IIWellHosoda71MaleM12 mmSubTG1b, 2, 0, IAPoorlyUmehara50MaleU35 mmTG2, 0, 0, IBPoorlyKume49FemaleM10 mm○Sub TG1b, 0, 0, IAWellFujiyoshi73FemaleU10 mmPG1b, 0, 0, IAModeratelyTakahashi50MaleL20 mmDG2, 0, 0, IBLELCTeraishi63MaleL25 mmDG2, 0, 0, IBModeratelyAndo65FemaleM20 mmSub TG1b, 0, 0, IAMucinousKim66MaleU73 mmTG2, 0, 0, IBMucinousKim46MaleU25 mmTG1b, 0, 0, IALELCYu54FemaleL31 mmLaparoscopic partial gastrectomy3, X, 0, IIAMucinousYu50FemaleM50 mmTG4a, 2, 0, IIIBMucinousYoo40FemaleU25 mmTG1b, 0, 0, IAMucinousMatsumoto58MaleUND○Radial gastrectomy1b, 0, 0, IALELCImamura68MaleU20 mmLaparoscopic PG1b, 0, 0, IAWellCha69MaleU24 mmTGNDFundic glandChen50MaleM22 mm○TG1b, 0, 0, IALELCLi44MaleU10 mm○Radial gastrectomy1b, 0, 0, IAPoorlyPresent case81MaleL35 mmDG2, 1, 0, IIAPoorly[^1][^2]

Thirteen patients (68.4%) were male and the average age of patients was 57 years (range: 40--81 years). The average tumor size was 26 mm (range: 10--73 mm). The tumor was located in the upper body in 9 patients, middle body in 5 patients, and lower body in 5 patients. Histological diagnoses consisted of poorly differentiated adenocarcinomas in 42.1% (8/19 cases), mucinous adenocarcinomas in 26.3% (5/19 cases), tubular adenocarcinomas in 26.3% (5/19 cases), and a fundic gland carcinoma in 5.3% (1/19 cases). Previous studies have suggested two hypotheses to describe the pathophysiology of GCSMT \[[@bib0110]\]. One hypothesis is that GCSMT is related with the mass-forming proliferation of cancer cells arising from heterotopic glands under the mucosa. It will be depended on the histological type and the cancer stroma volume, including such as mucinous carcinoma and medullary infiltration type. Another hypothesis is that GCSMT is related with the response of surrounding tissues to cancer invasion, including such as lymphocytic infiltration and local fibrosis. As lymphoepithelioma-like gastric carcinoma, it is characterized by carcinoma with intense stromal lymphocytic infiltration. Epstein-Barr virus (EBV) infection is also closely associated with the lymphocytic infiltration \[[@bib0115]\].

Our patient had a poorly differentiated adenocarcinoma without lymphocytic cyst and was negative for EBV, consistent with the medullary infiltration type.

In the treatment of GCSMT, preoperative diagnosis is necessary. Because GCSMT is a malignant tumor, its treatment typically requires systemic gastrectomy with en bloc lymphadenectomy \[[@bib0120]\]. This differs from the treatment of any other SMT \[[@bib0125]\]. However, a preoperative diagnosis of GCSMT is difficult because the tumor surface is covered with non-malignant epithelium. Therefore, the possibility of malignancy should be considered carefully in all cases of gastric SMT. Lim et al. reported that endoscopic biopsy in patients with gastric SMT appropriately diagnosed malignancy in approximately 33% (16 of 49 cases) \[[@bib0125]\]. In our reviewed cases, the endoscopic biopsy diagnosis rate of GCSMT was 47.4% of all actual cases (9 of 19 cases). In another 7 cases, despite negative endoscopic biopsy results, gastrectomy was performed owing to suspected malignancy (3 cases underwent intraoperative frozen section examinations; 2 cases underwent gastrectomy with lymphadenectomy; 1 case underwent partial gastrectomy without lymphadenectomy; and 1 case underwent laparoscopy and endoscopy cooperative surgery before curative resection). In the other 4 cases, endoscopic resection was performed to determine a definitive diagnosis, after which an additional radical cure excision was performed. Indeed, following definitive diagnoses, 18 cases underwent a systematic gastrectomy with an en bloc lymphadenectomy as an initial treatment.

EUS is a useful tool for the diagnosis of gastric diseases with an accuracy rate ranging from 45.5 to 66.7% \[[@bib0125],[@bib0130]\]. EUS could provide information on the tumor and its surrounding structures, as well as visualize the layer of origin of the gastric SMT. Kawamoto et al. reported the features of malignant SMT on EUS as follows: 1) tumor size \>30--50 mm, 2) rapid tumor growth, 3) echo-heterogeneity, and 4) irregular margins \[[@bib0135]\]. In our case, although EUS showed that the gastric tumor had a well-defined hypoechoic pattern, the tumor was arising from the third layer (submucosal layer) of the gastric wall. This is notable because this location differs from that of any other malignant gastric SMT, and especially of gastric GIST, which has malignant potential and which characteristically arises from the fourth layer (muscularis propria) \[[@bib0140]\]. Additional features which raise the suspicion of a malignancy GCSMT are elevated tumor markers and enlarged regional lymph nodes.

Finally, histopathological evaluation of the tumor with tissue sampling is essential to confirm the diagnosis. EUS-FNA is a less-invasive method and more effective for gastric SMT, with an accuracy of approximately 80% \[[@bib0125],[@bib0140]\]. Moreover, our patient underwent boring biopsy, with which adequate quantities of specimens from the tumor could be obtained for histopathological and immunohistochemical analysis. Adequate tissue sampling by EUS-FNA and boring biopsy could aid in establishing the accurate preoperative diagnosis, which, in turn, could help clinicians in selecting an optimal treatment strategy for the patients.

4. Conclusion {#sec0020}
=============

We reported a rare case of GCSMT with lymph node metastasis, which was diagnosed preoperatively. Based on our experience and results of the literature review, we recommend that in lesions suspected to be malignant gastric submucosal tumor, tissue sampling should be performed proactively, because the treatment strategy for GCSMT is quite a different from that for any other gastric SMT. For tissue sampling, EUS-FNA and boring biopsy are useful and minimally invasive. Finally, further studies including more cases are warranted to improve our knowledge of this important diagnosis and guide future clinical practice.
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[^1]: Abbreviations: L, lower body of the stomach; LELC, lymphoepithelioma-like carcinoma; M, middle body of the stomach; ND, not described; PG, proximal gastrectomy; TG, total gastrectomy; TNM, tumor-node-metastasis; U, upper body of the stomach.

[^2]: Japanese Gastric Cancer Association 14th Edition.
